Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$58.24
-0.1%
$49.06
$38.91
$147.03
$1.68B0.7845,497 shs485,922 shs
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$81.93
-0.2%
$95.75
$78.65
$118.01
$1.88B0.53412,654 shs304,064 shs
NovoCure Limited stock logo
NVCR
NovoCure
$17.38
-1.2%
$16.36
$9.82
$21.45
$2.05B0.971.75 million shs637,126 shs
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$23.71
-3.3%
$28.10
$12.25
$37.77
$555.21M0.81297,571 shs507,485 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-2.17%-3.39%+12.74%+35.93%-31.09%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
-0.86%+3.96%-18.11%-17.46%-12.98%
NovoCure Limited stock logo
NVCR
NovoCure
-0.40%+9.60%+9.32%-2.55%+55.11%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
+1.49%-18.25%-15.60%+6.38%+94.99%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$58.24
-0.1%
$49.06
$38.91
$147.03
$1.68B0.7845,497 shs485,922 shs
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$81.93
-0.2%
$95.75
$78.65
$118.01
$1.88B0.53412,654 shs304,064 shs
NovoCure Limited stock logo
NVCR
NovoCure
$17.38
-1.2%
$16.36
$9.82
$21.45
$2.05B0.971.75 million shs637,126 shs
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$23.71
-3.3%
$28.10
$12.25
$37.77
$555.21M0.81297,571 shs507,485 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-2.17%-3.39%+12.74%+35.93%-31.09%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
-0.86%+3.96%-18.11%-17.46%-12.98%
NovoCure Limited stock logo
NVCR
NovoCure
-0.40%+9.60%+9.32%-2.55%+55.11%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
+1.49%-18.25%-15.60%+6.38%+94.99%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.10
Hold$68.0016.77% Upside
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
2.44
Hold$110.6034.99% Upside
NovoCure Limited stock logo
NVCR
NovoCure
2.14
Hold$21.2021.98% Upside
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
2.67
Moderate Buy$38.4061.96% Upside

Current Analyst Ratings Breakdown

Latest TCMD, NVCR, LMAT, and INSP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/11/2026
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
Lower Price TargetBuy$40.00 ➝ $39.00
8/5/2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
Lower Price TargetEqual Weight$104.00 ➝ $94.00
8/5/2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
DowngradeOutperformMarket Perform
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Reiterated RatingSector Weight
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Set Price Target$54.00
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Reiterated RatingHold$54.00 ➝ $62.00
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Reiterated RatingSector Perform$60.00
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Set Price Target$75.00
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Boost Price TargetNeutral$55.00 ➝ $60.00
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Boost Price TargetNeutral$54.00 ➝ $60.00
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Boost Price TargetOutperform$55.00 ➝ $65.00
(Data available from 8/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$911.98M1.85$2.86 per share20.35$28.56 per share2.04
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$249.60M7.51$2.90 per share28.30$18.38 per share4.46
NovoCure Limited stock logo
NVCR
NovoCure
$655.35M3.09N/AN/A$2.90 per share5.99
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$329.52M1.63$1.11 per share21.28$9.80 per share2.42
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$145.42M$4.6212.6138.314.4315.03%8.64%7.45%N/A
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$57.73M$2.8528.7525.852.3725.02%15.63%10.06%N/A
NovoCure Limited stock logo
NVCR
NovoCure
-$136.23M-$1.30N/AN/AN/A-21.25%-44.00%-15.85%10/29/2026 (Estimated)
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$19.09M$1.0821.9517.83N/A7.10%11.62%9.26%N/A

Latest TCMD, NVCR, LMAT, and INSP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/10/2026Q2 2026
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$0.1350$0.34+$0.2050$0.34$85.52 million$85.70 million
8/4/2026Q2 2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$0.8070$0.74-$0.0670$0.74$71.47 million$70.38 million
8/3/2026Q2 2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-$0.2359$0.14+$0.3759$0.01$194.72 million$200.58 million
7/23/2026Q2 2026
NovoCure Limited stock logo
NVCR
NovoCure
-$0.3315-$0.13+$0.2015-$0.13$172.44 million$183.58 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/AN/AN/AN/AN/A
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$1.001.22%+16.05%35.09%14 Years
NovoCure Limited stock logo
NVCR
NovoCure
N/AN/AN/AN/AN/A
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
N/AN/AN/AN/AN/A

Latest TCMD, NVCR, LMAT, and INSP Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/28/2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
quarterly$0.250.95%8/20/20268/20/20269/3/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/A
8.55
6.16
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
0.40
16.31
13.96
NovoCure Limited stock logo
NVCR
NovoCure
0.58
2.89
2.70
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
N/A
4.24
3.78

Institutional Ownership

CompanyInstitutional Ownership
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
94.91%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
84.64%
NovoCure Limited stock logo
NVCR
NovoCure
84.61%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
83.43%

Insider Ownership

CompanyInsider Ownership
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.20%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
7.40%
NovoCure Limited stock logo
NVCR
NovoCure
6.55%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
2.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
1,33328.91 million28.27 millionOptionable
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
49022.87 million21.18 millionOptionable
NovoCure Limited stock logo
NVCR
NovoCure
1,605116.45 million108.82 millionOptionable
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
1,08622.65 million22.18 millionOptionable

Recent News About These Companies

Tactile Systems Technology, Inc. Q2 2026 Earnings Call Summary
Tactile Systems Technology: Q2 Earnings Snapshot
Tactile Systems Technology, Inc. Reports Second Quarter 2026 Financial Results
Tactile Systems Technology Q2 Earnings Call Highlights

New MarketBeat Followers Over Time

Media Sentiment Over Time

Inspire Medical Systems stock logo

Inspire Medical Systems NYSE:INSP

$58.24 -0.04 (-0.08%)
Closing price 03:59 PM Eastern
Extended Trading
$58.00 -0.24 (-0.41%)
As of 05:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

LeMaitre Vascular stock logo

LeMaitre Vascular NASDAQ:LMAT

$81.93 -0.20 (-0.24%)
Closing price 04:00 PM Eastern
Extended Trading
$82.21 +0.28 (+0.35%)
As of 05:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

NovoCure stock logo

NovoCure NASDAQ:NVCR

$17.38 -0.21 (-1.19%)
Closing price 04:00 PM Eastern
Extended Trading
$17.26 -0.13 (-0.72%)
As of 05:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

Tactile Systems Technology stock logo

Tactile Systems Technology NASDAQ:TCMD

$23.71 -0.80 (-3.26%)
Closing price 04:00 PM Eastern
Extended Trading
$23.74 +0.02 (+0.11%)
As of 05:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.